BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16825374)

  • 1. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.
    Brink AA; Meijer CJ; Wiegerinck MA; Nieboer TE; Kruitwagen RF; van Kemenade F; Fransen Daalmeijer N; Hesselink AT; Berkhof J; Snijders PJ
    J Clin Microbiol; 2006 Jul; 44(7):2518-23. PubMed ID: 16825374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.
    Dijkstra MG; Heideman DA; van Kemenade FJ; Hogewoning KJ; Hesselink AT; Verkuijten MC; van Baal WM; Boer GM; Snijders PJ; Meijer CJ
    J Clin Virol; 2012 Jun; 54(2):147-51. PubMed ID: 22445557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.
    van Baars R; Bosgraaf RP; ter Harmsel BW; Melchers WJ; Quint WG; Bekkers RL
    J Clin Microbiol; 2012 Dec; 50(12):3937-43. PubMed ID: 23015677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
    Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
    J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.
    Gustavsson I; Sanner K; Lindell M; Strand A; Olovsson M; Wikström I; Wilander E; Gyllensten U
    J Clin Virol; 2011 Aug; 51(4):255-8. PubMed ID: 21632283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
    Zhao C; Austin RM
    Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity.
    Darlin L; Borgfeldt C; Forslund O; Hénic E; Dillner J; Kannisto P
    J Clin Virol; 2013 Jan; 56(1):52-6. PubMed ID: 23017435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.
    Bais AG; van Kemenade FJ; Berkhof J; Verheijen RH; Snijders PJ; Voorhorst F; Babović M; van Ballegooijen M; Helmerhorst TJ; Meijer CJ
    Int J Cancer; 2007 Apr; 120(7):1505-10. PubMed ID: 17205514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection.
    Onuma T; Kurokawa T; Shinagawa A; Chino Y; Yoshida Y
    Int J Clin Oncol; 2020 Oct; 25(10):1854-1860. PubMed ID: 32583223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agreement of self- and physician-collected samples for detection of high-risk human papillomavirus infections in women attending a colposcopy clinic in Thailand.
    Phoolcharoen N; Kantathavorn N; Krisorakun W; Sricharunrat T; Teerayathanakul N; Taepisitpong C; Sornsamdang G; Krongthong W; Saeloo S
    BMC Res Notes; 2018 Feb; 11(1):136. PubMed ID: 29458440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-sampling versus physician-sampling for human papillomavirus testing.
    Agorastos T; Dinas K; Lloveras B; Font R; Kornegay JR; Bontis J; de Sanjose S
    Int J STD AIDS; 2005 Nov; 16(11):727-9. PubMed ID: 16303065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
    Hesselink AT; Bulkmans NW; Berkhof J; Lorincz AT; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2006 Oct; 44(10):3680-5. PubMed ID: 17021097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.